2014
DOI: 10.2478/s11686-014-0204-8
|View full text |Cite
|
Sign up to set email alerts
|

Immunomodulation of ALT-2 and TLR may collude in antigen specific T cell hyporesponsiveness: Proposed mechanism for elevated IL-10 levels in Balb/C mice

Abstract: ALT-2, a novel antigen belonging to the chromadorea ALT-2 family of the filarial nematode is proved to clear filarial parasites in Jirds. In order to increase the protection efficacy by stimulating the cell mediated immunity, MPLA a detoxified derivative of LPS known to induce the cellular response, was used in this study as an adjuvant on mice models. ALT-2+MPLA formulation elicited a high titer of total IgG antibody, with profoundly increased levels of IgG2b. Reduced splenocyte proliferation was observed in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…A chimeric protein construct comprising thioredoxin, transglutaminase and abundant larval transcript-2 (ALT-2) showed enhanced immunological response [48]. The hyper responsiveness of ALT-2 is also well documented with its T-cell and B-cell-specific responses [49,50]. The reactivity of ALT-2 protein with human clinical sera was tested by ELISA using EN, MF and CP sera (n D 10) from endemic regions.…”
Section: Immuno-reactivity With Human Clinical Seramentioning
confidence: 99%
“…A chimeric protein construct comprising thioredoxin, transglutaminase and abundant larval transcript-2 (ALT-2) showed enhanced immunological response [48]. The hyper responsiveness of ALT-2 is also well documented with its T-cell and B-cell-specific responses [49,50]. The reactivity of ALT-2 protein with human clinical sera was tested by ELISA using EN, MF and CP sera (n D 10) from endemic regions.…”
Section: Immuno-reactivity With Human Clinical Seramentioning
confidence: 99%